AMRA Medical will present research about MRI-based body composition analysis on individuals with liver disease at the Liver Meeting, sponsored by the American Association for the Study of Liver Diseases (AASLD).
Specifically, four abstracts will be presented at the meeting, which is scheduled for November 12-15. The following abstracts will be presented:
- Noninvasive muscle biomarkers predict all-cause mortality in nonalcoholic fatty liver disease.
- Radiomics-based coronary heart disease signature in liver transplant recipients with nonalcoholic fatty liver disease.
- Liver transplant recipients with nonalcoholic fatty liver disease have worse muscle composition profile.
- Natural rate of change in body composition on waitlist and the first 200 days after liver transplant.
